Post cystectomy adjuvant chemotherapy: a clinical routine?
Sternberg, C.N.
Progress in Clinical and Biological Research 378: 117-124
1992
ISSN/ISBN: 0361-7742 PMID: 1301572 Document Number: 399917
Document emailed within 1 workday
Related Documents
Schmid, H.P.; Studer, U.E. 1997: Adjuvant chemotherapy after cystectomy for bladder tumors staged as superior or equal to pT3 Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 7(1): 102-104Takashi, M.; Murase, T.; Aota, Y.; Nagai, T.; Kinjo, T.; Sabashi, M.; Shimoji, T.; Miyake, K.; Hamajma, N.; Mizuno, S. 1988: Multivariate evaluation of survival factors and postoperative adjuvant chemotherapy in patients with bladder cancer treated by radical cystectomy Hinyokika Kiyo. Acta Urologica Japonica 34(8): 1377-1381
Kato, T.; Hirai, T. 1997: Significance and problem of post-operative adjuvant chemotherapy for colorectal cancer Nihon Geka Gakkai Zasshi 98(3): 396-402
Ichihashi, H.; Yamauchi, M.; Watanabe, T.; Takagi, H.; Kondo, T. 1988: Prospective adjuvant chemotherapy of mitomycin C plus HCFU for colorectal cancer (2d report)--6-year survival after surgery: Tokai Cooperative Study Group of Surgical Adjuvant Chemotherapy Gan no Rinsho. Japan Journal of Cancer Clinics 34(4): 451-456
Hotta, T.; Takifuji, K.; Arii, K.; Yokoyama, S.; Matsuda, K.; Higashiguchi, T.; Tominaga, T.; Oku, Y.; Yamaue, H. 2006: Clinical impact of adjuvant chemotherapy on patients with stage III colorectal cancer: l-LV/5FU chemotherapy as a modified RPMI regimen is an independent prognostic factor for survival Anticancer Research 26(2b): 1425-1432
Fetting, J.H.; Siminoff, L.A.; Piantadosi, S.; Abeloff, M.D.; Damron, D.J.; Sarsfield, A.M. 1990: Effect of patients' expectations of benefit with standard breast cancer adjuvant chemotherapy on participation in a randomized clinical trial: a clinical vignette study Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 8(9): 1476-1482
Stöckle, M. 1994: Adjuvant polychemotherapy after radical cystectomy of metastatic bladder cancer Der Urologe. Ausg. a 33(6): 568-575
Nakajima, T. 1991: Issues of adjuvant chemotherapy in gastric cancer: its clinical significance Gan to Kagaku Ryoho. Cancer and ChemoTherapy 18(6): 952-957
Takashima, S.; Tomita, F.; Saito, H.; Gotoda, H.; Kinami, Y.; Miyazaki, I.; Yamaguchi, A. 1991: Clinical effect of postoperative adjuvant chemotherapy for advanced colorectal cancer--comparisons of between tegafur (FT) and UFT Gan to Kagaku Ryoho. Cancer and ChemoTherapy 18(13): 2315-2324
Pietrzak, K.; Sablińska, B.; Zieliński, J. 1993: Clinical analysis and evaluation of the results of adjuvant treatment (radiotherapy and chemotherapy) in ovarian carcinoma European Journal of Gynaecological Oncology 14(Suppl): 133-139
Gansauge, F.; Ramadani, M.; Schwarz, M.; Beger, H.G.; Lotspeich, E.; Poch, B. 2007: The clinical efficacy of adjuvant systemic chemotherapy with gemcitabine and NSC-631570 in advanced pancreatic cancer Hepato-Gastroenterology 54(75): 917-920
Nabuurs, M.J.; Bokhout, B.A.; van der Heijden, P.J. 1986: Clinical experience in the use of an adjuvant in the prevention of edema disease/post-weaning diarrhea in piglets Tijdschrift Voor Diergeneeskunde 111(20): 1001-1005
Blohmer, J.U.; Paepke, S.; Kissner, L.; Elling, D.; Fleige, B.; Grineisen, Y.; Lichtenegger, W. 1999: Dose- intensified, preoperative and adjuvant chemotherapy in patients with T3- and T4- breast cancer: toxicity, clinical and pathological remission Zentralblatt für Gynakologie 121(11): 522-525
Roth, J.A.; Pass, H.I.; Flanagan, M.M.; Graeber, G.M.; Rosenberg, J.C.; Steinberg, S. 1988: Randomized clinical trial of preoperative and postoperative adjuvant chemotherapy with cisplatin, vindesine, and bleomycin for carcinoma of the esophagus Journal of Thoracic and Cardiovascular Surgery 96(2): 242-248
Neoptolemos, J.P.; Baker, P.; Beger, H.; Link, K.; Pederzoli, P.; Bassi, C.; Dervenis, C.; Friess, H.; Büchler, M. 1997: Progress report. A randomized multicenter European study comparing adjuvant radiotherapy, 6-mo chemotherapy, and combination therapy vs no-adjuvant treatment in resectable pancreatic cancer (ESPAC-1) International Journal of Pancreatology: Official Journal of the International Association of Pancreatology 21(2): 97-104
Sternberg, C.N.; Yagoda, A.; Scher, H.I.; Whitmore, W.F.; Herr, H.W.; Morse, M.J.; Sogani, P.C.; Bosl, G.; Watson, R.C.; Hollander, P.S. 1988: Neo-adjuvant M-VAC chemotherapy trials in transitional cell carcinoma: perspectives for first line chemotherapy Progress in Clinical and Biological Research 260: 551-555
Todoroki, T. 2000: Chemotherapy for bile duct carcinoma in the light of adjuvant chemotherapy to surgery Hepato-Gastroenterology 47(33): 644-649
Izawa, J.I.; Chin, J.L.; Winquist, E. 2006: Timing cystectomy and perioperative chemotherapy in the treatment of muscle invasive bladder cancer Canadian Journal of Urology 13(Suppl 3): 48-53
Kurita, A.; Takashima, S.; Nakata, M.; Kubo, Y.; Saiki, T.; Ohsumi, S.; Yokoyama, N.; Tanada, M.; Takiyama, W.; Saeki, H. 1997: Granisetron versus granisetron plus methylprednisolone in the prevention of chemotherapy induced nausea and vomiting--in adjuvant chemotherapy, including CDDP against gastric cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 24(1): 49-54
Asaumi, J. 1997: Influence of stage classification, tumor differentiation and mode of invasion against clinical and histopathological effects on low dose sequential methotrexate and 5-fluorouracil administration as neo-adjuvant chemotherapy for oral squamous cell carcinoma In Vivo 11(2): 147-151